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The examination of the physiological role of CaMKII has made substantial progress in non-epithelial systems but little is known about its
function in secretory epithelial cells. A prototypic exocrine cell, the acid secreting gastric parietal cell, largely redistributes its cytoplasmic
tubulocisternal membranes (TC) to the secretory apical membrane (SA) after stimulation. We here present a dependence of physiological response
on partitioned initial CaMKII activities redistributed between TC and SA. Initial acid secretion after cholinergic stimulation has doubled if
activities of phosphatases PP1/PP2A and protein kinase PKC-α were inhibited by the inhibitors calyculin A and Gö 6976. CaMKII appears to be
integrated in multienzyme complexes each specific for TC and SA. Therein, PP1/PP2A and PKC-α were found to permanently counteract initial
CaMKII activities in different modes of transregulation. Remarkably, a dys-transregulated, hyperactive CaMKII at TC did not result in an
increased acid secretion to the same extent. A simple mathematical model to estimate the share of TC- and SA-associated CaMKII activities in
cholinergically induced acid secretion suggests that TC-associated CaMKII appears to autoregulate its contribution to the physiological response
by a negative feedback control. Subcellular distribution and stimulus-dependent redistribution of domain-associated CaMKII signalosomes
indicate a fine balanced, adaptive system to guarantee a stable physiological response.
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CaMKII acts as a multifunctional molecular detector of Ca2+
in signal transduction of neuronal, endocrine and exocrine cells
[1]. Therein, CaMKII exhibits a subtle autoregulatory mecha-
nism beyond a simple switch on- and off-mode. Autopho-
sphorylation shifts CaMKII activity from total Ca2+-dependence
to total independence on free Ca2+ [1,2]. Hence, after Ca2+-Abbreviations: AP, dimethylamine-aminopyrine; [Ca2+]i, free intracellular
Ca2+-concentration; CaMKII, Ca2+/calmodulin-dependent protein kinase II;
carbachol, (2-hydroxyethyl)trimethylammonium chloride carbamate; FK506,
tacrolimus; Gö 6976, 12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-
5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole; KN-62, 1-[N, O-Bis(5-isoquinoline-
sulfonyl)-N-methyl-L-tyrosyl]-4-phenyl-piperazine; Ro 31-8220, 3-[1-[3-(ami-
dinothio)propyl]-1H-indol-3-yl]-3-(1-methyl-1H-indol-3-yl)maleimide; SA,
stimulus-associated membrane; TC, tubulocisternal membranes
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doi:10.1016/j.bbamcr.2005.11.012dependent triggering of autophosphorylation, CaMKII is able to
act even after a drop of [Ca2+]i (concentration of free
intracellular Ca2+). Most information of the refined autopho-
sphorylation and autoregulation mechanism of CaMKII were
predominantly elucidated for isolated, neuronal CaMKII iso-
forms, however, CaMKII also plays an important role in some
epithelial cells, presumably to perform a spatio-temporal
decoding of Ca2+.
In the gastric parietal cell, a prototypic cell to study
exocrine secretion, CaMKII is expressed in two different
isoforms, CaMKII-γ, and -δ, exhibiting enzymatic properties
similar to neuronal CaMKII [3–7]. Evidence indicates that
CaMKII is an integral ruler of the cholinergically-stimulated
signal transduction pathway for gastric acid secretion [8,9].
CaMKII of gastric parietal cells is localized to subcellular
apical domains of tubulocisternae (TC) in the physiological
resting state as well as of the secretory apical (SA) membrane
after cholinergic stimulation [9–11]. On TC, CaMKII is the
Fig. 1. Effect of various kinase modulators on calyculin A- or carbachol-induced
acid secretion. Calyculin A (CA, 0.1 nM) augmented basal and carbachol (0.1
mM)-stimulated AP uptake. The enhancing effect of Gö 6976 (Gö, 10 μM) but
not of Ro 31-8220 (Ro, 0.1 μM) on carbachol (0.1 mM)-stimulated [14C]
aminopyrine (AP) uptake was additionally increased by calyculin A (0.1 nM).
Basal AP uptake was performed in the absence of any secretagogue but the
presence of ranitidine (0.1 mM). 100% [14C]AP uptake corresponds with 16.2
nmol 10−6 cells−1 45−1 min−1. Results represent means±S.E.M. from n=3 to 4
experiments. *, significantly different from control without calyculin A, **,
significantly different from control in the presence of calyculin A, each Pb0.05.
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state of parietal cells [9].
Each TC and SA carry the proton pump, and represent a
terminal, physiological state of the parietal cell. In stimulated
cells, TC are much less abundant in cytoplasm than in resting
cells since TC stimulus-dependently translocate to the apical
membrane to fuse. Consequently, TC contribute to acid
secretion at least by positioning the H+-K+-ATPase to the
apical membrane. Other functions of TC in acid secretion are
discussed [12]. After cholinergic stimulation, activated CaMKII
of TC redistributes to SA [9]. CaMKII associated with SA is
thought to directly mediate acid secretion but function of TC-
associated CaMKII is unknown [9].
We here present evidence that compartment-dependent
control and contribution to acid secretion of TC- and SA-
associated CaMKII signalosome remarkably differ. Initial
activities of CaMKII localized to TC or SA are differently
restricted by co-localized phosphoprotein phosphatases and
protein kinase C. TC-associated CaMKII signalosomes seem to
autoregulate their quantity of active CaMKII to translocate to
SA. The contribution of different CaMKII signalosomes in
exocrine function was probed by modeling a variety of
inhibition and stimulation experiments.
2. Material and methods
2.1. Chemicals
Calmodulin, calyculin A, Gö 6976 (12-(2-cyanoethyl)-6,7,12,13-tetrahydro-
13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole), KN-62 (1-[N, O-
bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl-piperazine), and Ro
31-8220, (3-[1-[3-(amidinothio)propyl]-1H-indol-3-yl]-3-(1-methyl-1H-indol-
3-yl)maleimide, bisindolylmaleimide IX) were obtained from Calbiochem
(Bad Soden, Germany). FK506 (tacrolimus) was from A.G. Scientific Inc.
(USA). ATP containing 370 GBq mol−1 γ-[32P]ATP was obtained from ICN
(Meckenheim, Germany). [Dimethylamine-14C]aminopyrine of 3.92 GBq mol−1
was from Amersham Bioscience (Freiburg, Germany). Leupeptin and pepstatin
Awere from Bachem, (Heidelberg, Germany). Pefabloc SC was purchased from
Roche (Mannheim, France). All other fine chemicals were from Sigma
(Deisenhofen, Germany) if not stated otherwise.
2.2. Primary culture of gastric parietal cells and estimation of acid
secretion
For primary culture to assess gastric acid secretion, parietal cells were
isolated from “White New Zealand” male rabbits performed as recently
described [9].
The secretion of H+ of cultured rabbit parietal cells was indirectly
determined by the uptake of [14C]AP ([dimethylamine-14C]aminopyrine) as
previously described [9]. The non-specific [14C]AP accumulation was obtained
by blocking acid secretion with omeprazole in control assays (10 μM;
AstraZeneca, Wedel, Germany). The non-specific background was subtracted
from each specific value (Fig. 1).
2.3. Preparations of TC, apical membrane, SA-vesicles and
purification of CaMKII
Preparations of apical membrane of resting state, TC, and SA-vesicles of the
homogenate of rat gastric mucosal cells were performed as described [9] with
here mentioned moderate modifications. The pellet after centrifugation at
1000×g was named P1, after 30,000×g P2, and after 100,000×g P3,
respectively. The continuous sucrose gradient 13–50% (w/v) to enrich TCfrom P3 was fractioned in 20 fractions of 0.5 ml each. Additionally, SA was
enriched from P1 in a two-step gradient utilizing 18% (w/v) Ficoll as described
[9]. Each fraction was analyzed for the protein concentration, the H+-K+-ATPase
activity, and the K+–phosphatase activity of the H+-K+-ATPase. The H+-K+-
ATPase activities of the highest enriched SA fraction or TC fraction were
12.9±2.4-fold or 17.7±1.1-fold, respectively, each compared to the postnuclear
supernatant (S0). Additional enrichment of TC was achieved by immunopre-
cipitation against a mouse monoclonal anti-H+-K+-ATPase (β-subunit) antibody
of clone 2G11 (RBI, Natick, MA), or an anti-H+-K+-ATPase (subunit β)
antibody kindly gifted from S. Karvar and J. Forte (University of Berkeley,
USA). Enrichment of subcellular domains was also monitored by Western blot
analysis (Fig. 2). In highly enriched H+-K+-ATPase-carrying TC, neither Na+-
K+-ATPase (Fig. 3a), nor significant levels of actin were detectable.
For in vitro phosphorylation studies, hetero-oligomeric CaMKII was
purified to apparent homogeneity from the homogenate of hog gastric mucosa
by differential bio-chromatographical procedures according to the protocol
presented in [7]. Purified cPKC containing PKC-α certified to be free of
possibly co-purified proteases was obtained from Roche (Mannheim, Germany).
Transphosphorylation assays with PKC-α towards CaMKII were performed as
described [13].
2.4. Protein kinase assays and Western blot analysis
Phosphorylation assays with CaMKII were performed as described [13]. To
determine transphosphorylation activity of CaMKII, autocamtide-II (KKALRR-
QETVDAL; Bachem, Heidelberg, Germany) was utilized as a specific CaMKII
substrate peptide (60 μM). Phosphorylation assays to analyze by Western
blotting were stopped with a denaturizing and reducing assay buffer for SDS
polyacrylamide gel electrophoresis as described [6].
Immunoblotting was performed as described [6]. First antibody (rabbit
polyclonal anti-(rat)CaMKII-δ2 directed against association domain and purified
immunogen CaMKII-δ2 association domain as a 29-kDa bacterially expressed
and isolated polypeptide [6] were kindly provided by M. Osterhoff and M.
Möhlig (DIFE, Potsdam, Germany), rabbit polyclonal anti-active, autonomy-site
phosphorylated rat CaMKII antibody (Promega, Mannheim, Germany); anti-
peptide rabbit polyclonal anti-PKC-α antibody and corresponding peptide
(Roche, Mannheim, Germany), monoclonal anti-(mouse/rat/human)PKC-α
Fig. 2. Enrichment of subcellular domains of gastric mucosa. Enrichment of (a)
TC as well as (b) SA vesicles of parietal cell-containing rat gastric mucosa was
monitored by immunoblotting against the rabbit polyclonal anti-H+-K+-ATPase
α-subunit. Fractions S0, P1, P2 and P3 result from intermediate steps of the
enrichment procedure (see Materials and methods). TC were finally enriched by
immunoprecipitation (IP) against the β-subunit of the H+-K+-ATPase. “IP-S”
represents the supernatant after immunoprecipitation.
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1681) (Santa Cruz Biotechnology, Santa Cruz, USA), rabbit polyclonal anti-H+-
K+-ATPase subunit α, kindly gifted from A. Smolka (Medical University of
South Carolina, Charleston, SC)) was incubated for 1 h at room temperature.
After washing, an appropriate secondary antibody was utilized. Its binding was
visualized by using the enhanced chemiluminescence detection system
(Amersham Bioscience, Braunschweig, Germany) according to the manufac-
turer's instructions. For kinetics of domain-associated CaMKII activities, we
determined very similar results for rat, and pig without significant differences
(data not shown).
To detect putative CaMKII docking sites on Western blots, the most active
protein–protein interaction binding site of CaMKII, the association domain, was
used. For far Western blots, isolated CaMKII-δ association domain was diluted
in TBST containing 0.5% (w/v) BSA, and added for 1 h at room temperature to
skim milk-blocked blot membrane exposing proteins of TC. Each step of the
“overlay” assay was carried out with gentle agitation. After 3 times washing for
total 30 min with TBST, the anti-CaMKII-δ2 antibody was applied for 1 h. After
washing, an appropriate secondary antibody conjugated to horseradish
peroxidase was incubated for 1 h. Protein–protein interactions were visualized
by the enhanced chemiluminescence detection system (Amersham Bioscience).
2.5. Analysis of data
Data are expressed as means±S.E.M. of at least three independent
experiments (n=3). Each assay of an experiment was performed at least three
times. ANOVA and Dunnett correction were used to compare data between 3
or more groups for statistical significance. Differences were taken as
significant at Pb0.05. Double-reciprocal plotting (Fig. 3c) was done with
“Grafit” (Erithacus Ltd., UK). Interpolated integrals were calculated with
“Scientist” (MicroMath, USA).3. Results
3.1. Inhibition of PP1/PP2A or of PKC-α or both enhance
carbachol-stimulated AP uptake
Calyculin A (0.1 nM) augmented basal AP uptake 2.4-fold,
and carbachol (0.1 mM)-induced AP uptake 1.3-fold, respec-
tively. In combination with carbachol and calyculin A, Gö 6976
more than doubled (2.1-fold) the carbachol-stimulated but not
basal AP uptake (Fig. 1). Combining calyculin A with Ro 31-
8220 was less effective on carbachol-evoked AP uptake than
combining calyculin Awith Gö 6976. Both calyculin A and Ro
31-8220 increased basal AP uptake similar as calyculin A alone(Fig. 1). As examined elsewhere, carbachol (0.1 mM)-evoked
acid secretion of cultured rabbit gastric parietal cells was
concentration-dependently suppressed by the potent inhibitor of
CaMKII KN-62 down to the level of secretagogue-independent,
basal acid secretion [8,9]. As only PKC-α as a member of
conventional PKC's, and PKC-ε as a novel PKC's are detected
in rabbit parietal cells [14,15], Gö 6976 is here specific for
PKC-α, and Ro 31-8220 for PKC-α and PKC-ε. Gö 6976 as
well as Ro 31-8220 act with a similar IC50 for PKC-α (2.3 nM
and 5 nM, respectively) [16,17]. In principle, Ro 31-8220 also
inhibits other protein kinases, S6K1, MAPKAP-K1/RSK2, and
MSK1 (reviewed in [18]) which, however, regulate gene
expression rather than agonist-dependent signal transduction
of exocytosis. In the case of acid secretion, these kinases are not
known to regulate cholinergically-induced acid secretion.
3.2. Localization and co-localization of PKC-α to CaMKII on
TC
CaMKII has been demonstrated to be localized to TC [6]. We
here show that TC carry putative specific binding sites for
CaMKII (Fig. 3a). Overlaid and bound CaMKII association
domain revealed clear protein–protein interactions with poly-
peptides of gastric mucosal homogenate (lane 4, 56.5 (range of
CaMKII), 48, 38, 36 kDa (black asterisks)), plasma membrane
(lane 5, 56.5 (range of CaMKII), 38 kDa, (white asterisk)), and
TC (lane 6, 56.5 (range of CaMKII), 48, 38, 35, 34 kDa (black
asterisks)) (Fig. 3a). Some additional protein–protein interac-
tions of low signal are to detect. In lane 1 (homogenate), lane 3
(TC), and to a lesser extent in lane 2 (plasma membrane) of the
control blot without the “overlaid” association domain, we
detected a clear signal in the range of 56.5 kDa with the anti-
CaMKII-δ2 antibody (Fig. 3a), very likely CaMKII as
demonstrated in [6].
We showed elsewhere that after carbachol-stimulation, PKC-
α translocates to the plasma membrane of gastric parietal cells
[10]. PKC-α is the only isoenzyme of cPKC which has been
detected in cytosol as well as at the plasma membrane of gastric
parietal cells of different species (dog, rat, rabbit) analyzed so
far and to our knowledge [10,14,15,19]. This suggests the
indispensable role of PKC-α in parietal cell function. Here, we
show that PKC-α, but not PKC-ε, has been detected in fractions
Nr. 6 to 8 of highly enriched H+-K+-ATPase-carrying TC (Fig.
3b). There has also been a co-localization of PKC-α to non-
active CaMKII on TC (fractions Nr. 7 and 8). The specificity of
the immunoreaction of the anti-PKC-α antibody was proven by
specific blocking of its binding site with the corresponding
immunogenic synthetic peptide, and by comparison to the
specific immunoreaction against rat forebrain cytosol as a
naturally rich source of PKC-α (Fig. 3c).
3.3. Phosphorylation of epithelial CaMKII
As indicated in Fig. 3b, there may not only be a structural but
also a functional linkage between CaMKII and PKC-α.
Therefore, we simulated their interaction in vitro on the level
of purified enzymes with various molar ratios. PKC-α
Fig. 3. Localization and co-localization of PKC-α with CaMKII on TC. (a) A far Western blot to detect putative CaMKII binding proteins is shown (lanes 4–6).
Isolated association domain of CaMKII-δ2 was subjected to proteins of TC presented on a Western blot membrane after SDS-polyacrylamide gel electrophoresis (lane
5). Bindings were detected with an antibody directed against the association domain of CaMKII-δ2. 25 μg proteins were separated and blotted for each lane. Black or
white asterisks indicate the positions of most intensive CaMKII association domain bindings in homogenate (H: 48, 38, 36 kDa), plasma membrane (PM: 38 kDa), or
TC (48, 38, 35, 34 kDa). Molecular size of CaMKII-δ in the range of 56.5 kDa is indicated. (b) PKC-α co-localized to H+-K+-ATPase and CaMKII on highly enriched
rat gastric TC. TC were fractionized by density in a 13–50% (w/v) continuous sucrose gradient. Abundances of PKC-α, PKC-ε, H+-K+-ATPase, Na+-K+-ATPase,
CaMKII, and autonomy-site phosphorylated CaMKII as active CaMKII (CaMKII-P) on TC were tested each with appropriate antibodies. Numbers correspond with
the fraction number of 20 fractions in total. Antibody–antigen bindings in panels a and b were visualized by the ECL detection system. (c) Specificity of
immunoreaction of the anti-PKC-α antibody was tested by pre-incubation of the anti-PKC-α antibody with the corresponding immunogenic PKC-α peptide. C, control
(rat forebrain cytosol), TC, TC of rat; each lane 25 μg; lane +, pre-incubation of anti-PKC-α antibody with immunogenic PKC-α peptide, lane −, pre-incubation
without peptide. (d) Double reciprocal plot of PKC-dependent phosphorylation of purified gastric mucosal CaMKII in the absence of Ca2+/calmodulin. The inset
shows a typical autoradiograph in the size range of double banded CaMKII of n=3 independent experiments. Under performed conditions and the absence of PKC
(0*), CaMKII exhibited no phosphorylation. “CaMKII PKC−1” in the inset is to read as “mol mol−1” in correspondence to the double reciprocal plot. The absolute
amount of CaMKII (10 ng) was constant for each assay of 50 μl volume.
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inset). Double reciprocal plotting showed an apparent constant
of phosphorylation of CaMKII with Kp=1.1±0.11 mol PKC
mol− 1 CaMKII− 1 with Vmax=0.25±0.01 mol Pi mol
− 1
CaMKII−1 min−1 (Fig. 3d).
CaMKII carries multiple phosphorylation sites which are not
all characterized [1,2]. If comparing total phosphorylation of
TC-associated CaMKII to its autonomy site specific phosphor-
ylation of orthologous T286 or T287, respectively [1],
especially TPA (10−7 M)-dependent activation of PKC resulted
in a 2.6-fold, or in combination with calyculin A (10−8 M) a
3.2-fold higher total phosphorylation than specific phosphory-
lation of the autonomy site of CaMKII. Activity of TC-
associated CaMKII was restricted in the presence of TPA (Fig.
4a, b). Inhibition of PKC-α by Gö 6976 (10−5 M) or incombination with calyculin A (10−8 M) increased the activity of
CaMKII with a moderate relative higher total phosphorylation
than phosphorylation of T286 (Fig. 4a, b). In the absence of Ca2+
or the presence of calyculin A, total phosphorylation of CaMKII
was 2.7- or 2.8-fold stronger phosphorylated than at its
autonomy site.
3.4. TC-associated CaMKII activity is restricted by PP1/PP2A
but at SA only by both PP1/PP2A and PKC-α
Since CaMKII is, at least, localized to TC of resting parietal
cells [6,9], and to SA after carbachol-stimulation [9], we
compared the initial kinetics of TC- and SA-associated CaMKII
to purified CaMKII. In gastric parietal cells, cholinergic
stimulation compared to other secretagogues is most relevant
Fig. 4. Comparison of total of CaMKII phosphorylation to autonomy site T286-specific phosphorylation. (a) Highly enriched TC were in vitro incubated under
conditions for ATP-dependent phosphorylation in the presence or absence of various PKC modulators or calyculin A (CA) for 10 min γ-[32P]ATP was present for
determination of total phosphorylation but not for T286-specific phosphorylation of CaMKII. The latter was determined with an anti-phospho-T286 CaMKII antibody.
Free Ca2+-ions (0.1 mM) were present during phosphorylation with the exception where indicated (“w/o Ca”). Data of phosphorylation in the presence of Gö 6976 and
calyculin Awere normalized to 100% for total as well as T286-specific phosphorylation of CaMKII. (b) Ratio of total CaMKII phosphorylation (P) to T286-specific
phosphorylation (P-T286). For abbreviations, see Fig. 1.
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stimulation [20,21]. Therefore, the in vitro kinetics of CaMKII
between 0 and 4 min were determined.
As purified gastric mucosal CaMKII is uncoupled from any
distinct modulating component, it was used as a reference to
non-transregulated CaMKII activity (Fig. 5, hatched bar).
Purified gastric CaMKII autophosphorylated with 21.1 mmol
Pi per mol CaMKII per min at room temperature (data not
shown). The existence of a working CaMKII-phosphatase
system in gastric parietal cells is here demonstrated for TC-Fig. 5. Effect of PKC-α and PP1/PP2A on the initial total activation of CaMKII.
TC-associated CaMKII activity in the presence of PKC-modulators and/or
phosphatase modulators after 4 min in vitro autophosphorylation (black bars)
was compared to SA (grey bars), or to purified gastric mucosal CaMKII (control
II, hatched bar). Control I shows CaMKII activity of TC or SA in the absence of
any pharmacological agent. Percentage is relative to 100% activity of purified
(“pure”) gastric mucosal CaMKII after 4 min autoactivation in vitro according
[13]. Significant differences to the corresponding TC (*) or SA (**) control I,
Pb0.05 or less.associated CaMKII: In the presence of the PP1/PP2A-inhibitor
calyculin A, we obtained a 9.8-fold higher total CaMKII-
activity on TC after 4 min than without calyculin A (Fig. 5).
FK506 increased 2.5-fold the initial activity of TC-associated
CaMKII (Fig. 5). Addition of either Gö 6976 (10−5 M) or Ro
31-8220 (10−7 M) to calyculin A dampened the potentiating
effect of calyculin A on CaMKII activity (Fig. 5).
Surprisingly for SA, neither calyculin A alone, nor FK506,
nor Gö 6976, nor Ro 31-8220, nor calyculin A combined with
Ro 31-8220 nor TPA had a significant in vitro effect on SA-
related CaMKII signalosome activity (Fig. 5). A combined
treatment with calyculin A and Gö 6976, however, doubled (2.2-
fold compared to control) in vitro the SA-associated CaMKII
activity after 4min (Fig. 5). Each inhibitor Gö 6976, calyculin A,
FK506 or TPA does not affect the activity of CaMKII directly,
Ro 31-8220 only at concentrations in the μmolar range.
3.5. Estimation of contribution of TC- and SA-associated
CaMKII activity in carbachol-evoked acid secretion
Both TC- and SA-associated CaMKII activities seem to
contribute to cholinergically-induced H+ secretion. We have
established a simple mathematical model to estimate the
contribution of each SA- and TC-associated CaMKII activity.
Decline-curves are generated from our mathematical model of
total CaMKII activity as a function of share of TC-associated
CaMKII signalosome activity relative to control. This is a
highly abstract and simplified model to predict how pharma-
cological agents affect the activity of CaMKII signaling com-
plexes (CaMKII signalosomes) to modulate cholinergically-
stimulated initial acid secretion. Despite simplicity of the
model, it may help to capture behaviors of the secretory system.
Activities of TC- as well as SA-related CaMKII in the
presence or absence of CaMKII signalosome-affecting agents
Fig. 6. Estimation of the contribution of activities of TC- and SA-associated
CaMKII signalosome in cholinergically induced acid secretion in a simplified
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set into (1):
f ðxÞ ¼ ð½SA þ ½TCx1=½SAcontrol
þ ½TCcontrolx1Þ100% for xN0 ð1Þ
therein: [SA], modulated SA-CaMKII activity, [SA]control, SA-
CaMKII activity in the absence of any pharmacological kinase-
or phosphatase-modulator, [TC], modulated TC-CaMKII activ-
ity, and [TC]control, TC-CaMKII activity in the absence of any
pharmacological kinase- or phosphatase-modulator. For each
pharmacological agent used, its function f(x) and the
corresponding AP uptake have been plotted (Fig. 6; Table 1).
Term (1) is used to compare to normalized AP uptake (Fig. 6;
Table 1). For [SA]=[SA]control and [TC]=[TC]control as in the
case of absence of kinase or phosphatase modulators, there is f
(x)=100% which represents total CaMKII signalosome activity
of both SA and TC. For x=1, there is an equal contribution of
[SA] and [TC] as well as of [SA]control and [TC]control to total
CaMKII signalosome activity.
To estimate the theoretical capacity of the TC- and SA-
CaMKII signalosome system, each left (b0) and right (b∞) limes
of f(x) were calculated:
b0 ¼ lim
xY0
f ðxÞ ð2Þ
and
bl ¼ lim
xYl
f ðxÞ ð3Þ
Results for each specific modulator are summarized in Table 1.
Ratio of limits is determined as follows:
b0b
1
l ¼ z ð4Þ
we observed a remarkable correlation between z and the
intersection xi (z≈xi (5)) of decline curves according to f(x) (1),
and the corresponding normalized H+ secretion for each used
pharmacological agent compared to control. Therefore, z is
useful to predict the corresponding cholinergically-induced acid
secretion in a semi cell-free system utilizing isolated TC and
SA.
Individual results of comparison of z with xi are presented in
Table 1, row F. Modulation of TC- or SA-associated CaMKII
activities as well as carbachol-induced acid secretion were
performed with KN-62, calyculin A (Fig. 6a, Table 1), Gö 6976,
or Gö 6976 plus calyculin A (Fig. 6b, Table 1), and Ro 31-8220
or Ro 31-8220 plus calyculin A (Fig. 6c, Table 1).mathematical model. Relative CaMKII activities in dependence of (a) calyculin A
(CA) alone or in combination with (a–c) kinase inhibitors (KN-62; Gö 6976 (Gö),
Ro 31-8220 (Ro)) were plotted according to f(x)=([SA]+[TC] x−1/[SA]control+
[TC]control x
−1)100% which models the share of each SA- or TC-associated
CaMKII activity during acid secretion of cholinergically-induced parietal cells.
Values for x=1 as well as limits of f(x) are summarized in Table 1. Each graph of f
(x) crosses the corresponding graph of acid secretion at xi with the exception if
CaMKII was inhibited by KN-62. xi is supposed to correspond with the
contribution of TC-associated CaMKII activity during cholinergically evoked acid
secretion. As z≈xi, extent of cholinergically induced acid secretion is to predict
even on the level of isolated TC and SA analyzing their CaMKII signalosome
activities in vitro. For details, see Estimation of contribution of TC- and SA-
associated CaMKII activity in carbachol-evoked acid secretion as well as Table 1.4. Discussion
The results described in this study demonstrate that the initial
CaMKII activity associated with TC of resting state parietal
cells, and with SA of cholinergically stimulated parietal cells
remarkably differ. CaMKII appears to be integrated in a
membrane-associated signaling complex designated “signalo-
some” of various CaMKII-transregulating enzymes comprising
phosphoprotein phosphatases and other protein kinases. On each
Table 1
Contribution of SA- and TC-associated CaMKII activities in regulating
cholinergically-evoked acid secretion
Modulator (A)
f(1)(%)
(B)
b0 (%)
(C)
b∞ (%)
(D)
z
(E)
AP-uptake (%)
(F) intersection
(xi)
Control 100.0 100.0 100.0 1.0 100.0 Parallel
+KN-62 52.6 46.5 58.2 1.3 44.0 No
+CA 257.0 96.3 695.6 7.1 133.9 7.1
+Gö 135.9 96.1 236.9 2.5 138.5 1.1
+Gö +CA 236.9 187.0 364.6 2.0 216.1 2.0
+Ro 124.1 78.5 249.6 3.2 119.6 3.2
+Ro +CA 173.1 70.9 452.7 6.3 92.7 7.7
Relative total CaMKII activities of SA and TC were calculated according to (1)
(see for details section 3.5). (A) f(x) for x=1; (B) for b0= limxY0 f(x); (C)
b∞=limxYl f(x); (D) ratio b∞b0
− 1= z of left (x→0) to the right (x→∞) limes
of f(x); (E) AP-uptake; (F) intersection xi between total CaMKII signalosome
activity from each f(x) and corresponding AP uptake (E). Control total
activities are defined as 100%. For abbreviations of modulators or
corresponding graphs, see Fig. 1 or 6.
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sphorylation is transregulated by PP1, PP2A, PP2B, and PKC-α
to different extents. A system of both TC- and SA-associated
CaMKII signalosomes represents a refined and dynamic module
to mediate and a stable cholinergically induced H+-secretion.
CaMKII has been described as an integral key enzyme in
cholinergically-stimulated gastric parietal cells, a prototypic cell
type to study exocrine secretion [9]. Applying the irreversible
CaMKII inhibitor KN-62 [22] to parietal cells, carbachol-
stimulated acid secretion is inhibited down to the basal,
secretagogue-independent level [8,9]. As reported, partial
inhibition of carbachol (1 to 100 μM)-evoked acid secretion
by KN-62 was clearly compensated by the PP1/PP2A-inhibitor
calyculin A [23]. For histamine-stimulated H+ secretion, neither
an inhibitory effect of KN-62, nor a KN-62-compensatory nor
enhancing effect of calyculin A was observed [23]. This
suggests no leading role of CaMKII in histamine-evoked H+-
secretion. Gastric mucosal membrane of carbachol-stimulated
rats as well as of histamine-stimulated rabbits were described
each as rich sources of phosphoserine–phosphothreonine-
specific phosphatases, comprising PP1 and PP2A [23,24]. In
the present study, we confirm that both calyculin A-induced
acid secretion and calyculin A-enhanced carbachol-stimulated
acid secretion has been sensitive to KN-62 which shows that
CaMKII and PP1/PP2A are functionally linked to the
corresponding signaling pathways for H+ secretion. On the
level of TC, the clear calyculin A-dependent increase of the
inceptive CaMKII activity corroborates that PP1/PP2A are
involved in the transregulation of CaMKII activity.
PP2B (calcineurin), which is inhibited by FK506 (tacroli-
mus), has here been found to be less effective for TC or SA to
counteract the kinase activity of CaMKII than PP1/PP2A.
Although a role of PP2B for Ca2+-dependent signal transduc-
tion pathways in acid secretion has been suggested [25], in our
studies it does not appear to be an important part in regulating
the initial activity of the SA-associated CaMKII signalosome.
Virtually, PP2B has been shown to connect Ca2+-dependent
with protein kinase A-dependent signaling pathways bycounteracting the PKA-dependent phosphorylation of the
negative PP1-regulator I1 [26]. The effect of okadaic acid on
gastric parietal cells was tested, too. However, for gastric acid
secretion, okadaic acid showed nearly no effect [23]. Therefore,
we did not use okadaic acid in our analysis.
Although CaMKII and phosphoprotein phosphatases strong-
ly appear to play a role in acid secretion, their coordinated
interaction remains unclear. Our data indicate that the functional
linkage of TC- and SA-located CaMKII, PP1, PP2A, and PKC
is reflected in the kinetics of cholinergically induced acid
secretion of parietal cells. CaMKII and other TC-associated
enzymes such as PP1, PP2A, and PKC-α as well as here
detected CaMKII-anchoring proteins seem to build a modular
signalosome which gates transregulation of CaMKII activity
after triggering with [Ca2+]i. Such modular complexes integrat-
ing CaMKII are especially characterized for neuronal cells [27]
but rarely examined for epithelial cells. For neurons it was
shown that CaMKII and PP1 as well as PP2A are structurally
and functionally linked [28–30]. A balanced autophosphoryla-
tion of isolated CaMKII and its trans-dephosphorylation by
isolated PP1 results in an ultrasensitivity of CaMKII activity
towards [Ca2+]i [29,30] which may also be important for
epithelial CaMKII. Actually, a trans-deactivating effect on TC-
associated CaMKII appears to be predominantly mediated by
PP1/PP2A, and, to a lesser extent, by PKC-α in parietal cells.
Previous studies showed that in parietal cells PKC does not
seem to play a leading role in mediating agonist-induced acid
secretion (reviewed in [31]). In the muscarinic M3 acetylcho-
line-dependent receptor pathway, activation of CaMKII is a
prerequisite to forward acid secretion [9]. Co-activated PKC-α
[10], the only significantly expressed cPKC in rabbit parietal
cells [14,15], appears to attenuate CaMKII activity as well as
cholinergically-evoked H+ secretion [10,13]. The attenuating
effect of PKC-α on CaMKII activity in cholinergically evoked
rabbit parietal cells was shown by Gö 6976 as well as Ro 31-
8220 [10]. Each Gö 6976 and Ro 31-8220 had a compensatory
effect on CaMKII activity as well as on carbachol-induced acid
secretion if parietal cells were pre-incubated with KN-62 [10].
TPA-activated PKC did not seem to target the autonomy site
of CaMKII but other phosphorylation sites to down regulate
CaMKII activity. In the absence of Ca2+, most phosphorylation
of CaMKII was not at T286 but presumably at calmodulin
binding site. As known for neuronal CaMKII, basal autopho-
sphorylation which means in the absence of free Ca2+ occurs
predominantly at T306 of the calmodulin-binding site and
inactivates CaMKII [32].
The in vitro kinetics of SA-associated CaMKII activity has
been very different from that of associated with TC. In
principle, SA-associated CaMKII is pre-activated but exhibits
additional autoactivation in vitro. Initial CaMKII signalosome
activity of SA in vitro has been observed being robust to the
pharmacological blocking of PKC-α, or PP1/PP2A, or PP2B, as
well as to the TPA-dependent activation of PKC. Especially the
robustness of inceptive SA-associated CaMKII activity towards
activity of PP1/PP2A is remarkable compared to TC. At SA,
PP1/PP2A most effectively exhibited their trans-deactivation of
CaMKII only in combination with activity of PKC-α. This
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KII [13] are rarely counteracted by PP1/PP2A. This effect is
strongly reflected on the physiological level of acid secretion.
As SA-located CaMKII activity is, at least partially,
autonomous and relatively independent on activities of robust
towards inhibition of accompanying protein phosphatases or
PKC, an attenuated but robust autonomous CaMKII activity in
its SA signalosome seems to be necessary to promote
cholinergically-evoked acid secretion.
However, a share of non-autonomous CaMKII as to be found
on TC appears to contribute to cholinergically-induced acid
secretion. We have launched a simple mathematical model to
estimate the relative contribution of SA- and TC-associated
CaMKII signalosome activities to cholinergically induced acid
secretion. Theoretic estimation of the extent of acid secretion by
the model is possible as CaMKII has been revealed as a rate
limiting factor in the signaling pathway to cholinergically-
induced acid secretion [9]. Prediction works even if CaMKII
signalosome activity is pharmacologically affected. TC-associ-
ated CaMKII signalosome seems to be less robust towards
perturbations than the signalosome of SA. Perturbations of the
intermolecular interactions in the CaMKII signalosome, which
may result in a hyperactive CaMKII, did not result in an
overstimulated acid secretion to the same extent. The mathe-
matical model implies that TC-associated hyperactive CaMKII
leads to a reduced contribution of TC-associated CaMKII to the
total activity of the CaMKII signalosome system of both TC and
SA. As the SA-associated CaMKII signalosome has been more
robust to interferences than the TC signalosome, we assume that
transregulation of CaMKII activity is predominantly targeted on
the level of TC. Moreover, hyperactive CaMKII on TC may be
physiologically compensated by a reduced translocation of TC
to the secretory apical membrane.
Consequently, there appears to exist at least two ways to
restrict the activity of CaMKII after cholinergic stimulation: (a)
by limitation of CaMKII phosphotransferase activity via
counteraction of PP1/PP2A and PKC-α or both, and (b) by
restriction of the contribution of TC-associated CaMKII
signalosome to total CaMKII activity, possibly by restricting
the translocation of the TC signalosome to the secretory
membrane. Reduced translocation of CaMKII may be self-
regulated in a negative feedback. The second mechanism (b)
may be forced if mode (a) fails, likely induced in the case of a
dys-transregulated, hyperactive CaMKII of TC. Although
adaptation of CaMKII activity by transregulation, and a
supposed CaMKII-regulated negative feedback mechanism of
translocation of TC appear to guarantee a robust, physiological
response, there may be other, but still unknown mechanisms to
limit and distribute CaMKII activity in the epithelial cell.
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